Literature DB >> 21547740

Primary epithelial cell models for cystic fibrosis research.

Scott H Randell1, M Leslie Fulcher, Wanda O'Neal, John C Olsen.   

Abstract

When primary human airway epithelial (hAE) cells are grown in vitro on porous supports at an air-liquid interface (ALI), they recapitulate in vivo morphology and key physiologic processes. These cultures are useful for studying respiratory tract biology and diseases and for testing new cystic fibrosis (CF) therapies. This chapter gives protocols enabling creation of well-differentiated primary CF and non-CF airway epithelial cell cultures with non-proprietary reagents. We also discuss the production of retroviral and lentiviral vectors, the derivation of hAE cell lines, reporter gene assays, and the evolving science of gene overexpression and knockdown in ALI hAE cultures.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21547740     DOI: 10.1007/978-1-61779-120-8_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  56 in total

Review 1.  In Vitro Models to Study Human Lung Development, Disease and Homeostasis.

Authors:  Alyssa J Miller; Jason R Spence
Journal:  Physiology (Bethesda)       Date:  2017-05

2.  Comparative evaluation of miRNA expression between in vitro and in vivo airway epithelium demonstrates widespread differences.

Authors:  Peter Chen; Jeffrey D Edelman; Sina A Gharib
Journal:  Am J Pathol       Date:  2013-08-31       Impact factor: 4.307

3.  Type 2 alveolar cells are stem cells in adult lung.

Authors:  Christina E Barkauskas; Michael J Cronce; Craig R Rackley; Emily J Bowie; Douglas R Keene; Barry R Stripp; Scott H Randell; Paul W Noble; Brigid L M Hogan
Journal:  J Clin Invest       Date:  2013-06-10       Impact factor: 14.808

4.  Identification of the SPLUNC1 ENaC-inhibitory domain yields novel strategies to treat sodium hyperabsorption in cystic fibrosis airway epithelial cultures.

Authors:  Carey A Hobbs; Maxime G Blanchard; Omar Alijevic; Chong Da Tan; Stephan Kellenberger; Sompop Bencharit; Rui Cao; Mehmet Kesimer; William G Walton; Ashley G Henderson; Matthew R Redinbo; M Jackson Stutts; Robert Tarran
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-11       Impact factor: 5.464

Review 5.  Lung organoids: current uses and future promise.

Authors:  Christina E Barkauskas; Mei-I Chung; Bryan Fioret; Xia Gao; Hiroaki Katsura; Brigid L M Hogan
Journal:  Development       Date:  2017-03-15       Impact factor: 6.868

6.  Conditionally reprogrammed cells represent a stem-like state of adult epithelial cells.

Authors:  Frank A Suprynowicz; Geeta Upadhyay; Ewa Krawczyk; Sarah C Kramer; Jess D Hebert; Xuefeng Liu; Hang Yuan; Chaitra Cheluvaraju; Phillip W Clapp; Richard C Boucher; Christopher M Kamonjoh; Scott H Randell; Richard Schlegel
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

7.  Nonantibiotic macrolides prevent human neutrophil elastase-induced mucus stasis and airway surface liquid volume depletion.

Authors:  Robert Tarran; Juan R Sabater; Tainya C Clarke; Chong D Tan; Catrin M Davies; Jia Liu; Arthur Yeung; Alaina L Garland; M Jackson Stutts; William M Abraham; Gary Phillips; William R Baker; Clifford D Wright; Sibylle Wilbert
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-03-29       Impact factor: 5.464

8.  17β-Estradiol inhibits phosphorylation of stromal interaction molecule 1 (STIM1) protein: implication for store-operated calcium entry and chronic lung diseases.

Authors:  John T Sheridan; Rodney C Gilmore; Michael J Watson; Christopher B Archer; Robert Tarran
Journal:  J Biol Chem       Date:  2013-10-10       Impact factor: 5.157

9.  Tobacco Smoke Constituents Trigger Cytoplasmic Calcium Release.

Authors:  M Flori Sassano; Arunava Ghosh; Robert Tarran
Journal:  Appl In Vitro Toxicol       Date:  2017-06-01

Review 10.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.